Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
2.1%
1w
3.9%
1m
1.5%
3m
4.1%
6m
13.2%
1y
12.5%
all
14.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,123 2.1%
1,910
2,285
Company Overview

Sales
13,914 Cr
Growth: 19.7%
Profit after Tax
1,779 Cr
Growth: 1.6%
Large Cap
87,625 Cr
P/E: 49.2x
Industry P/E: 28.0x
Fundamentals

Sales (Cr) ₹ 13,914
Growth 19.7%
EBITDA 24.2%
P/S 6.3x
Dividend 0.0%
P/E 49.2x
Book Value ₹ 380
PEG Ratio 2.5x
ROE 11.8%
P/B 5.6x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)